Literature DB >> 26681305

Pulmonary Artery Dilation and Right Ventricular Function in Acute Kawasaki Disease.

Fujito Numano1,2, Chisato Shimizu3, Adriana H Tremoulet3,4, Dan Dyar4, Jane C Burns3,4, Beth F Printz4.   

Abstract

Coronary artery inflammation and aneurysm formation are the most common complications of Kawasaki disease (KD). Valvulitis and myocarditis are also well described and may lead to valvar regurgitation and left ventricular dysfunction. However, functional changes in the right heart have rarely been reported. We noted several acute KD patients with dilated pulmonary arteries (PA) and thus sought to systematically characterize PA size and right-heart function in an unselected cohort of KD patients cared for at a single clinical center. Clinical, laboratory, and echocardiographic data from 143 acute KD subjects were analyzed. PA dilation was documented in 23 subjects (16.1 %); these subjects had higher median right ventricle myocardial performance index (RV MPI), higher ratio of early tricuspid inflow velocity to tricuspid annular early diastolic velocity (TV E/e'), and lower median TV e' velocity compared to the non-PA dilation group (0.50 vs 0.38 p < 0.01, 4.2 vs 3.6 p < 0.05, and 13.5 vs 15.2 cm/s p < 0.01, respectively). Almost all subjects with PA dilation had improved PA Z-score, RV MPI, and TV E/e' in the subacute phase (p < 0.01). There were no significant differences in indices of left ventricle function between PA dilation group and non-PA dilation group. In summary, PA dilation was documented in 16 % of acute KD subjects. These subjects were more likely to have echocardiographic indices consistent with isolated RV dysfunction that improved in the subacute phase. The long-term consequence of these findings will require longitudinal studies of this patient population.

Entities:  

Keywords:  Kawasaki disease; Myocardial performance index; Pulmonary artery dilation; Right ventricle function; Tissue Doppler imaging

Mesh:

Year:  2015        PMID: 26681305     DOI: 10.1007/s00246-015-1303-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.838


  32 in total

1.  Microscopic polyangiitis and Kawasaki disease without overt clinical cardiovascular manifestations and with abnormal cardiovascular magnetic resonance findings.

Authors:  S Mavrogeni; G Papadopoulos; E Karanasios; D Georgakopoulos; M N Manoussakis
Journal:  Int J Cardiol       Date:  2009-01-09       Impact factor: 4.164

2.  Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequelae and regional wall motion abnormalities of the left ventricle.

Authors:  S Yonesaka; T Takahashi; T Matubara; T Nakada; H Furukawa; K Tomimoto; H Oura
Journal:  Jpn Circ J       Date:  1992-04

3.  Kawasaki disease in a pediatric intensive care unit: a case-control study.

Authors:  Samuel R Dominguez; Kevin Friedman; Ryan Seewald; Marsha S Anderson; Lisa Willis; Mary P Glodé
Journal:  Pediatrics       Date:  2008-09-22       Impact factor: 7.124

Review 4.  Aneurysms of the pulmonary arteries.

Authors:  T Bartter; R S Irwin; G Nash
Journal:  Chest       Date:  1988-11       Impact factor: 9.410

5.  Findings in the pulmonary vascular bed in the remote phase after Kawasaki disease.

Authors:  Masaya Sugimoto; Hirotaka Ishido; Mitsuru Seki; Satoshi Masutani; Akiko Tamai; Hideaki Senzaki
Journal:  Am J Cardiol       Date:  2012-01-19       Impact factor: 2.778

6.  Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission.

Authors:  Ying-Jui Lin; I-Chun Lin; Hong-Ren Yu; Hsuan-Chang Kuo; Kuender D Yang; Wei-Chiao Chang; Chi-Di Liang; Shih-Feng Liu; Ho-Chang Kuo
Journal:  Pediatr Cardiol       Date:  2012-07-19       Impact factor: 1.655

7.  Acute right ventricular myocarditis presenting with chest pain and syncope.

Authors:  Jennifer Mancio; Nuno Bettencourt; Marco Oliveira; Gustavo Pires-Morais; Vasco Gama Ribeiro
Journal:  BMJ Case Rep       Date:  2013-10-04

8.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

Review 9.  Kawasaki syndrome.

Authors:  Jane C Burns; Mary P Glodé
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

10.  Right ventricular Tei index in children: effect of method, age, body surface area, and heart rate.

Authors:  David A Roberson; Wei Cui
Journal:  J Am Soc Echocardiogr       Date:  2007-06       Impact factor: 5.251

View more
  2 in total

1.  Dual-source Computed Tomography for Evaluating Pulmonary Artery and Aorta in Pediatric Patients with Single Ventricle.

Authors:  Meng-Xi Yang; Zhi-Gang Yang; Yi Zhang; Ke Shi; Hua-Yan Xu; Kai-Yue Diao; Ying-Kun Guo
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

2.  Lipocalin-2-induced proliferative endoplasmic reticulum stress participates in Kawasaki disease-related pulmonary arterial abnormalities.

Authors:  Zhaoling Shi; Yue Yin; Chen Li; Hui Ding; Nan Mu; Yishi Wang; Shanshan Jin; Heng Ma; Manling Liu; Jie Zhou
Journal:  Sci China Life Sci       Date:  2020-09-09       Impact factor: 6.038

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.